Blood Biomarkers Signal Increased Risk of Alzheimer's & MND After Multiple Rugby Concussions
Results that show rugby players that have sustained multiple concussions present with markers of neurodegenerative disease development.
Life Science Players Join €23m European Project for Precision Medicine, PRECISEU
The project will bring together life science institutions across European nations in the interest of expanding development of and access to advanced therapy medicinal products.
Feinstein Institutes Links Blood Biomarkers to Psychosis in Alzheimer's Patients
The global aging population means that rates of Alzheimer's disease are expected to reach 14 million patients by 2060, many of whom will experience psychosis.
ZERO Precision Medicine Programme Reports Outstanding Efficacy in High-Risk Paediatric Cancers
The first-of-its-kind trial presents a positive outlook for cancer types with historically poor survival rates.
Hope for New Prognostic Biomarkers & Therapeutic Options From Tumour Metabolism-Targeting Breast Cancer Study
Understanding the interplay between the tumour microenvironment and immunometabolic states could unlock a wealth of therapeutic targets and biomarkers.
New Zika-Specific Synthetic Biomarker Can Differentiate From Dengue Virus
A test that identifies Zika distinct from dengue could make a definite impact to expectant mothers and reproductive-age women that are at risk from the mosquito-borne disease.
Meet Our Expert Speakers
Multi-Omics in Biomarker Discovery & Precision Medicine Online Symposium again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.
Confirmed speakers include:
Claudia Fredolini
Co-Director Clinical Proteomics and Immunology Platform,
Royal Institute of Technology KTH - ScilifeLab
Jia Guo
Associate Professor,
Arizona State University
Manuel Salto-Tellez
Professor,
The Institute of Cancer Research
Priyank Patel
Senior Scientist,
Boehringer Ingelheim